Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

This publication has 25 references indexed in Scilit:

• Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
  Molecular Therapy, 2017
• Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors
  Journal of the National Comprehensive Cancer Network, 2015
• Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
  Blood, 2015
• Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
  Journal of Clinical Oncology, 2014
• Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
• Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
  Journal of Clinical Oncology, 2012
• Involved Field Radiation After Autologous Stem Cell Transplant for Diffuse Large B-Cell Lymphoma in the Rituximab Era
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
• Involved-Field Radiotherapy Before High-Dose Therapy and Autologous Stem-Cell Rescue in Diffuse Large-Cell Lymphoma: Long-Term Disease Control and Toxicity
  Journal of Clinical Oncology, 2008
• Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
  Journal of Clinical Oncology, 1999
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995